Skip to main content
    • Aa
    • Aa

Cost-effectiveness of prophylaxis against on-demand treatment in boys with severe hemophilia A in Iran

  • Aliasghar Ahmad Kia Daliri (a1), Hassan Haghparast (a2) and Jahanara Mamikhani (a3)

Objective: The aim of this study was to assess the incremental cost-effectiveness of on-demand versus prophylactic hemophilia therapy in Iran from a third-party payers’ perspective.

Methods: A retrospective chart review of twenty-five type A hemophiliacs who were treated in three hemophilia treatment centers was conducted. The patients were boys 0–9 years old receiving one of two treatments: (i) prophylaxis with concentrate at clinic; (ii) concentrate at clinic as on-demand. Fourteen boys received on-demand infusions for bleeding events, and eleven boys received infusions prophylaxis. Data were extracted from documents in the hemophilia treatment centers during a period of approximately 6 months.

Results: The patients receiving prophylactic treatment had fewer bleeding events each month (mean, 0.26 versus 2.74) but used more concentrate (225.31 versus 87.20 units/kg per month). Average monthly cost per patient in the prophylaxis group was approximately 1.9 times higher than in the on-demand group. Compared with on-demand infusion, prophylaxis costs 3,201,656 Rials (€213.45) per bleeding event prevented.

Conclusion: Prophylactic care markedly reduces the number of bleeding episodes, but at considerable cost.

Linked references
Hide All

This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.

1. LM Aledort , RH Haschmeyer , H Pettersson . A longitudinal study of orthopaedic outcomes for severe factor-VIII-deficient haemophiliacs. The Orthopaedic Outcome Study Group. J Intern Med. 1994;236:391399.

2. E Berntorp , J Astermark , S Bjorkman , Consensus perspectives on prophylactic therapy for haemophilia:summary statement. Haemophilia. 2003;9 (Suppl 1):14.

4. DR Globe , RG Curtis , MA Koerper . Utilization of care in haemophilia: a resource- based method for cost analysis from the Haemophilia Utilization Group Study (HUGS). Haemophilia. 2004;10 (Suppl 1):6370.

7. RJ Liesner , K Khair , IM Hann . The impact of prophylactic treatment on children with severe haemophilia. Br J Haematol. 1996;92:973978.

8. B Lippert , K Berger , E Berntorp , Cost effectiveness of haemophilia treatment: A cross-national assessment. Blood Coagul Fibrinolysis. 2005;16:477485.

9. MJ Manco-Johnson , TC Abshire , AD Shapiro , Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia. N Engl J Med. 2007;357:535544.

10. C Martines-Murillo , S Quintana , R Ambriz , An economic model of haemophilia in Mexico. Haemophilia. 2004;10:917.

11. AH Miners , CA Sabin , KH Tolley , A Assessing the effectiveness and cost-effectiveness of prophylaxis against bleeding in patients with severe haemophilia and severe von Willebrand's disease. J Intern Med. 1998;244:515522.

12. AH Miners , CA Sabin , KH Tolley , Cost-utility analysis of primary prophylaxis versus treatment on-demand for individuals with severe haemophilia. Pharmacoeconomics. 2002;20:759774.

13. IM Nilsson , E Berntorp , T Lofqvist , Twenty-five years’ experience of prophylactic treatment in severe haemophilia A and B. J Intern Med. 1992;232:2532.

14. PS Smith , SM Teutsch , PA Shaffer , Episodic versus prophylactic infusions for hemophilia A: A cost-effectiveness analysis. J Pediatrics. 1996;129:424431.

15. TD Szucs , A Offner , W Schramm . Socioeconomic impact of haemophilia care: Results of a pilot study. Haemophilia. 1996;2:211217.

16.United Kingdom Haemophilia Centre Directors Organization Executive Committee. Guidelines on therapeutic products to treat haemophilia and other hereditary coagulation disorders. Haemophilia. 1997;3:6377.

17. HM Van Den Berg , K Fischer , JG Van Der Bom . Comparing outcomes of different treatment regimens for severe haemophilia. Haemophilia. 2003;9 (Suppl 1):2731.

Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

International Journal of Technology Assessment in Health Care
  • ISSN: 0266-4623
  • EISSN: 1471-6348
  • URL: /core/journals/international-journal-of-technology-assessment-in-health-care
Please enter your name
Please enter a valid email address
Who would you like to send this to? *



Full text views

Total number of HTML views: 1
Total number of PDF views: 16 *
Loading metrics...

Abstract views

Total abstract views: 835 *
Loading metrics...

* Views captured on Cambridge Core between September 2016 - 19th August 2017. This data will be updated every 24 hours.